26 April 2023

Cannabidiol: Legislative framework

spotlight topic:

The use of cannabidiol (CBD) in animals

1. Legislative framework Published 21 April 2023 When considering the legislative framework, it is important to distinguish between products that may fall under the Misuse of Drugs Act (Schedule 2 Class B), licenced medicinal products, and consumer products and food additives. The

Misuse of Drugs Act 1971
The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018
Drug licensing factsheet: cannabis, CBD and other cannabinoids
Cannabis based products for medicinal use in humans (CBPMs)
ACMD advice on consumer cannabidiol (CBD) products
Cannabidiol (CBD) guidance for England and Wales
- Cannabidiol (CBD) guidance for Northern Ireland
- Cannabidiol (CBD): Information for businesses about using CBD in food products

For those outside the UK it is important to check local legislation.

European Monitoring Centre for Drugs and Drug Addiction (2018) Medical use of cannabis and cannabinoids: Questions and answers for policymaking
FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)
World Health Organization (2018) Cannabidiol (CBD): Critical review report

Medicinal products Consumer products Online full-text available to Library members A range of library membership packages is available and MRCVS vets and RVNs can join the library for a heavily subsidised, annual fee.